While Celularity’s Biovance® and Biovance 3L products remained eligible for Medicare coverage under the now-withdrawn LCDs, Celularity CEO Dr. Robert…
MUMBAI, India, ISELIN, N.J. and LONDON, Oct. 28, 2025 /PRNewswire/ -- Hexaware Technologies Limited (NSE: HEXT), a global provider of…
Tuesday 23 September, 2025 London, UK - In a recent statement that has raised concerns and sparked debates worldwide, President…